Market Cap (In INR)
90.75 Billion
Revenue (In INR)
11.51 Billion
Net Income (In INR)
2 Billion
Avg. Volume
9054.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4636.55-5850.0
- PE
- -
- EPS
- -
- Beta Value
- 0.508
- ISIN
- INE199A01012
- CUSIP
- Y6008J118
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Milind Vasant Thatte M.B.A.
- Employee Count
- -
- Website
- https://www.pghealthindia.com
- Ipo Date
- 2002-07-01
- Details
- Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
More Stocks
-
PDSLPDS Limited
PDSL
-
NNGVFTesoro Minerals Corp.
NNGVF
-
LILMLilium N.V.
LILM
-
4992
-
COVHCovivio Hotels
COVH
-
PIONEEREMBPioneer Embroideries Limited
PIONEEREMB
-
SB
-
1685